drugset / Trial / NCT06188104

Efficacy of Topical 95% TCA in the Treatment of CIN 1 or Less After Low-grade Abnormality of Screening Test

NCT06188104

RandomizedParallel-groupTriple-blindTreatment

Summary

To evaluate the efficacy of topical 95% TCA in the treatment of CIN 1 or less after low grade abnormality of screening test

Timeline

Start
2023-11-30
Primary completion
2023-12-01
Completion
2023-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Trichloroacetic acid Small molecule 95 % Topical